2.5 million people may be missing out on ACA subsidies

An analysis from HHS said millions of additional customers could qualify for subsidies if they purchased plans off the Affordable Care Act (ACA) marketplace.

The agency estimated out of 6.9 million people who purchased coverage off the off-exchange individual market, 2.5 million may qualify for tax credits if they shopped on the ACA marketplace.

“More than nine million Americans already receive financial assistance through the Health Insurance Marketplace to help keep coverage affordable, but today’s data show millions more Americans could benefit,” HHS Sylvia Burwell said in a statement. “We encourage everyone to check out their options on HealthCare.gov or their state Marketplace and see if they qualify for financial assistance. Marketplace consumers who qualify for financial assistance usually have the option to buy coverage with a premium of less than $75 per month.”

Six states have more than 100,000 individuals who may be leaving subsidies on the table: California, Texas, Florida, North Carolina, Illinois and Pennsylvania.

Some of the off-exchange customers did have reasons not to shop for coverage.

“About 1.9 million either have incomes that would qualify them for Medicaid or place them in the Medicaid coverage gap or are ineligible to purchase Marketplace coverage due to immigration status, while the remainder could enroll in Marketplace qualified health plans,” HHS said.

If on and off-exchange customers were counted along with the uninsured who are eligible to use the marketplace, HHS said almost 80 percent of all marketplace-eligible Americans could receive income-based subsidies for buying coverage.

The agency has been trying to shine a spotlight on the availability of subsidies in reaction to increases in premiums in 2017 plans and the departures of major insurers like UnitedHealthcare, Aetna and Humana from many states.

Promoting subsidies isn’t likely to change the minds of ACA critics. When CMS Acting Administrator Andy Slavitt used their availability to defend the stability of exchanges in a congressional hearing, Rep. Tim Murphy, R-Pennsylvania, called that argument “absolutely phony.”

 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.